Literature DB >> 19231320

Relation of N-terminal pro B-type natriuretic peptide levels after symptom-limited exercise to baseline and ischemia levels.

P Marc van der Zee1, Hein J Verberne, Rianne C van Spijker, Jan P van Straalen, Johan C Fischer, Augueste Sturk, Berthe L F van Eck-Smit, Robbert J de Winter.   

Abstract

Circulating levels of B-type natriuretic peptide (BNP) and the amino-terminal portion of the prohormone (NT-proBNP) have been reported to increase immediately after myocardial ischemia. The association between extent of exercise-induced myocardial ischemia measured using myocardial perfusion scintigraphy and the magnitude and time course of changes in NT-proBNP was studied. One hundred one patients underwent symptom-limited exercise myocardial perfusion scintigraphy. Myocardial ischemia was assessed semiquantitatively. Serum samples were obtained before the start of exercise (baseline), at maximal exercise, and every hour up to 6 hours after maximal exercise. Myocardial ischemia was present in 37 patients (37%). NT-proBNP rapidly increased during exercise (to 113%, interquartile range 104 to 144, and 118%, interquartile range 106 to 142, of baseline, respectively), with a second peak at 4 (141%, interquartile range 119 to 169) and 5 hours (136%, interquartile range 93 to 188), respectively. Absolute changes between NT-proBNP at baseline and at maximum exercise in patients with versus without ischemia were similar (median, 30 pg/ml, interquartile range 7 to 45 vs 15, interquartile range 4 to 46, respectively, p = 0.230), but absolute change between baseline and the secondary peak was higher in patients with ischemia than in patients without ischemia (median 64 pg/ml, interquartile range 32 to 172 vs 34, interquartile range 19 to 85, respectively, p = 0.024). In multivariate linear stepwise regression analysis of determinants of changes in NT-proBNP after exercise, baseline NT-proBNP was the only independent determinant of absolute changes at maximum exercise, whereas the presence of ischemia was not predictive. Baseline NT-proBNP, cystatin C, and end-systolic volume were independent determinants of the absolute increase to secondary peak levels. In conclusion, myocardial ischemia per se did not lead to additional increases in NT-proBNP within 6 hours after exercise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19231320     DOI: 10.1016/j.amjcard.2008.11.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection.

Authors:  Alfred Hager; Florian Christov; John Hess
Journal:  Pediatr Cardiol       Date:  2012-02-29       Impact factor: 1.655

2.  Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers.

Authors:  Theodore Pipikos; Alkistis Kapelouzou; Diamantis I Tsilimigras; Yannis Fostinis; Marina Pipikou; Athanassios Theodorakos; Antonis N Pavlidis; Christos Kontogiannis; Dennis V Cokkinos; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

3.  Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia.

Authors:  M Başkurt; F Aktürk; K Keskin; P Canbolat; B Karadag; A Kaya; A Yildiz; U Coskun; K Kilickesmez; O Esen; S K Muniboglu
Journal:  Cardiovasc J Afr       Date:  2011 Mar-Apr       Impact factor: 1.167

4.  Plasma B-type natriuretic peptide levels are poorly related to the occurrence of ischemia or ventricular arrhythmias during symptom-limited exercise in low-risk patients.

Authors:  Andreu Porta; José A Barrabés; Jaume Candell-Riera; Luis Agulló; Santiago Aguadé-Bruix; Gustavo de León; Jaume Figueras; David Garcia-Dorado
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

5.  Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.

Authors:  Alexander T Limkakeng; J Clancy Leahy; S Michelle Griffin; Yuliya Lokhnygina; Elias Jaffa; Robert H Christenson; L Kristin Newby
Journal:  Open Heart       Date:  2018-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.